abstract |
The present invention relates to compounds of Formula (I), wherein R1, R2, R3, A1, A2, A3, A4 and D have the meaning described herein. The present invention also relates to pharmaceutical compositions comprising such compounds and therapeutic uses thereof in cancers by inhibiting mTOR and PI3K. |